{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T20:10:47Z","timestamp":1712175047415},"reference-count":20,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0971-4065.157799","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T12:07:18Z","timestamp":1456834038000},"page":"125","source":"Crossref","is-referenced-by-count":12,"title":["Neutrophil gelatinase-associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease"],"prefix":"10.25259","volume":"26","author":[{"given":"ML","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Sachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KK","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.157799-1","unstructured":"World Health Organization. Preventing Chronic Disease: A Vital Investment. Geneva: WHO; 2005."},{"key":"key-10.4103\/0971-4065.157799-2","first-page":"1296","volume-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.157799-3","first-page":"350","volume-title":"Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease","author":"Briet","year":"2006","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.157799-4","first-page":"2154","volume-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"key-10.4103\/0971-4065.157799-5","first-page":"572","volume-title":"Vascular calcification in chronic kidney disease","author":"Goodman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.157799-6","first-page":"1959","volume-title":"Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease","author":"Kent","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.157799-7","first-page":"1908","volume-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.157799-8","first-page":"491","volume-title":"The role of renal proximal tubular cells in diabetic nephropathy","author":"Phillips","year":"2003","journal-title":"Curr Diab Rep"},{"key":"key-10.4103\/0971-4065.157799-9","first-page":"1569","volume-title":"Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD)","author":"Smith","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.157799-10","unstructured":"United States Renal Data System. Annual Report of the US Renal Data System 2007. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2007."},{"key":"key-10.4103\/0971-4065.157799-11","first-page":"2038","volume-title":"Prevalence of chronic kidney disease in the United States","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"key-10.4103\/0971-4065.157799-12","first-page":"63","volume-title":"The burden of cardiovascular disease in patients with chronic kidney disease and in end-stage renal disease","author":"Zoccali","year":"2008","journal-title":"Contrib Nephrol"},{"key":"key-10.4103\/0971-4065.157799-13","first-page":"337","volume-title":"Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease","author":"Bolignano","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.157799-14","first-page":"909","volume-title":"Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease","author":"Liu","year":"2013","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.157799-15","doi-asserted-by":"crossref","unstructured":"Wu Y, Su T, Yang L, Zhu SN, Li XM. Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis. Am J Med Sci 2010;339:537-42.","DOI":"10.1097\/MAJ.0b013e3181dd0cb1"},{"key":"key-10.4103\/0971-4065.157799-16","first-page":"4065","volume-title":"Lipocalin 2 is essential for chronic kidney disease progression in mice and humans","author":"Viau","year":"2010","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0971-4065.157799-17","first-page":"c130","volume-title":"Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study","author":"Nielsen","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"key-10.4103\/0971-4065.157799-18","first-page":"255","volume-title":"Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease","author":"Bolignano","year":"2008","journal-title":"Kidney Blood Press Res"},{"key":"key-10.4103\/0971-4065.157799-19","first-page":"181","volume-title":"Correlation of serum neutrophil gelatinase-associated lipocalin with acute kidney injury in hypertensive disorders of pregnancy","author":"Patel","year":"2013","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"key-10.4103\/0971-4065.157799-20","first-page":"967","volume-title":"Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage","author":"Mori","year":"2007","journal-title":"Kidney Int"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:39:14Z","timestamp":1712173154000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/neutrophil-gelatinase-associated-lipocalin-as-a-biomarker-of-disease-progression-in-patients-with-chronic-kidney-disease\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["157799"],"URL":"https:\/\/doi.org\/10.4103\/0971-4065.157799","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}